Evidence map›Paper›PMID 34525109›Full record

ArticlePloS one2021

Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation.

Maria Jose Lista, Pedro M Matos, Thomas J A Maguire, Kate Poulton, Elena Ortiz-Zapater, Robert Page, Helin Sertkaya, Ana M Ortega-Prieto, Edward Scourfield, Aoife M O'Byrne and 27 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Evaluation of the persistence of SARS-CoV-2 (ATCC® VR-1986HK™) on two different food contact materials: flow pack polyethylene and polystyrene food trays.Lebensmittel-Wissenschaft + [i.e. und] Technologie. Food science + technology. Science + technologie alimentaire · 2021
    Article
  18. Assessment of inactivation procedures for SARS-CoV-2.The Journal of general virology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Maria Jose ListaKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Pedro M MatosKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Thomas J A MaguireKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0003-1034-4926
Kate PoultonKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Elena Ortiz-ZapaterKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0002-7437-4772
Robert PageKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Helin SertkayaKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Ana M Ortega-PrietoDept. Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-9023-0103
Edward ScourfieldDept. Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Aoife M O'ByrneKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Clement BoutonKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Ruth E DickensonKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0003-0027-6317
Mattia FicarelliKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Jose M Jimenez-GuardeñoDept. Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-1726-8033
Mark HowardKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0001-9779-5302
Gilberto BetancorKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Rui Pedro GalaoKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0003-3368-5053
Suzanne PickeringKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Adrian W SignellKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0003-4620-6891
Harry WilsonKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0002-3185-1073
Penelope CliffViapath pathology laboratories at St Thomas' Hospital, London, United Kingdom.ORCID 0000-0001-6558-6039
Mark Tan Kia IkCentre for Infectious Diseases Research, St Thomas' Hospital, London, United Kingdom.ORCID 0000-0002-7774-3836
Amita PatelCentre for Infectious Diseases Research, St Thomas' Hospital, London, United Kingdom.ORCID 0000-0001-5945-7791
Eithne MacMahonCentre for Infectious Diseases Research, St Thomas' Hospital, London, United Kingdom.
Emma CunninghamCentre for Infectious Diseases Research, St Thomas' Hospital, London, United Kingdom.
Katie DooresKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Monica AgromayorKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Juan Martin-SerranoKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Esperanza PeruchaKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0002-7802-0875
Hannah E MischoKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Manu Shankar-HariKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Rahul BatraCentre for Infectious Diseases Research, St Thomas' Hospital, London, United Kingdom.
Jonathan EdgeworthCentre for Infectious Diseases Research, St Thomas' Hospital, London, United Kingdom.
Mark ZuckermanKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Michael H MalimKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Stuart NeilKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.
Rocio Teresa Martinez-NunezKing's College London Diagnostics Team at Guy's Campus, London, United Kingdom.ORCID 0000-0003-2507-4738

Funding

X-ray Crystallographic Fragment Screening CoreU54AI150472 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ENGELMAN, ALAN N. · 2019 to 2021
$15.7M
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIVR01AI076119 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI SARAFIANOS, STEFAN G · 2008 to 2018
$4.1M
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIVR37AI076119 · NIAID · EMORY UNIVERSITY · PI Stefan G Sarafianos · 2020 to 2026
$3.6M
Medical Research Council MC_PC_15068Medical Research Council MR/S000844/1Medical Research Council MR/S009191/1Medical Research Council MR/S023747/1NIAID NIH HHS R01 AI076119NIAID NIH HHS R37 AI076119NIAID NIH HHS U54 AI150472Wellcome Trust 102871/Z/13/ZWellcome Trust 106223/Z/14/ZWellcome Trust 207442/Z/17/ZWellcome Trust 218537/Z/19/Z
6 · The paper itself

Abstract

There is a worldwide need for reagents to perform SARS-CoV-2 detection. Some laboratories have implemented kit-free protocols, but many others do not have the capacity to develop these and/or perform manual processing. We provide multiple workflows for SARS-CoV-2 nucleic acid detection in clinical samples by comparing several commercially available RNA extraction methods: QIAamp Viral RNA Mini Kit (QIAgen), RNAdvance Blood/Viral (Beckman) and Mag-Bind Viral DNA/RNA 96 Kit (Omega Bio-tek). We also compared One-step RT-qPCR reagents: TaqMan Fast Virus 1-Step Master Mix (FastVirus, ThermoFisher Scientific), qPCRBIO Probe 1-Step Go Lo-ROX (PCR Biosystems) and Luna® Universal Probe One-Step RT-qPCR Kit (Luna, NEB). We used primer-probes that detect viral N (EUA CDC) and RdRP. RNA extraction methods provided similar results, with Beckman performing better with our primer-probe combinations. Luna proved most sensitive although overall the three reagents did not show significant differences. N detection was more reliable than that of RdRP, particularly in samples with low viral titres. Importantly, we demonstrated that heat treatment of nasopharyngeal swabs at 70°C for 10 or 30 min, or 90°C for 10 or 30 min (both original variant and B 1.1.7) inactivated SARS-CoV-2 employing plaque assays, and had minimal impact on the sensitivity of the qPCR in clinical samples. These findings make SARS-CoV-2 testing portable in settings that do not have CL-3 facilities. In summary, we provide several testing pipelines that can be easily implemented in other laboratories and have made all our protocols and SOPs freely available at https://osf.io/uebvj/.

Indexed as

Hot TemperatureVirus InactivationCOVID-19COVID-19 TestingEpidemicsHumansNasopharynxReagent Kits, DiagnosticReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionRNA, ViralSARS-CoV-2Sensitivity and SpecificitySpecimen HandlingWorkflowReagent Kits, DiagnosticRNA, Viral

Identifiers

PMID34525109
PMCPMC8443028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.